Decision-making in pituitary disease is critically dependent on high quality imaging of the sella and parasellar region. Magnetic resonance imaging (MRI) is the investigation of choice and, for the majority of patients, combined T1 and T2 weighted sequences provide the information required to allow surgery, radiotherapy (RT) and/or medical therapy to be planned and long-term outcomes to be monitored. However, in some cases standard clinical MR sequences are indeterminate and additional information is needed to help inform the choice of therapy for a pituitary adenoma (PA). This article reviews current recommendations for imaging of PA, examines the potential added value that alternative MR sequences and/or CT can offer, and considers how the use of functional/molecular imaging might allow definitive treatment to be recommended for a subset of patients who would otherwise be deemed unsuitable for (further) surgery and/or RT.

中文翻译：

---

垂体腺瘤的现代成像。

垂体疾病的决策关键取决于蝶鞍和鞍旁区域的高质量成像。磁共振成像（MRI）是一种选择的研究，对于大多数患者，组合的T1和T2加权序列可提供所需的信息，以使您能够计划外科手术，放射治疗（RT）和/或药物治疗以及长期结果被监视。但是，在某些情况下，标准的临床MR序列不确定，还需要其他信息以帮助告知垂体腺瘤（PA）治疗的选择。本文回顾了当前对PA成像的建议，研究了替代MR序列和/或CT可以提供的潜在增值，